REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels
Clinical trial NCT05669755 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05669755
- Sponsor
- Novo Nordisk A/S
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2027-09-01
- Enrollment
- 7101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.